Recent Advances in Multiple Myeloma: Applying Real-world Evidence to Clinical Practice

被引:0
作者
Fonseca, Rafael [1 ]
Costa, Luciano [2 ]
Nooka, Ajay K. [3 ]
Pianko, Matthew James [4 ]
机构
[1] Mayo Clin, Phoenix, AZ 85054 USA
[2] ONeal Comprehens Canc Ctr, Birmingham, AL USA
[3] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[4] Univ Michigan Hlth, Ann Arbor, MI USA
来源
ONCOLOGY-NEW YORK | 2022年 / 36卷 / 08期
关键词
DEXAMETHASONE; LENALIDOMIDE; BORTEZOMIB;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:506 / 510
页数:5
相关论文
共 50 条
[41]   Real-World Treatment of Patients With Relapsed/Refractory Myeloma [J].
Ntanasis-Stathopoulos, Ioannis ;
Gavriatopoulou, Maria ;
Terpos, Evangelos ;
Dimopoulos, Meletios A. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06) :379-385
[42]   Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma [J].
Chari, Ajai ;
Romanus, Dorothy ;
Palumbo, Antonio ;
Blazer, Marlo ;
Farrelly, Eileen ;
Raju, Aditya ;
Huang, Hui ;
Richardson, Paul .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01) :8-+
[43]   Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myeloma [J].
Mark, Tomer ;
Falkenstein, Angelica ;
Kish, Jonathan .
FUTURE ONCOLOGY, 2022, 18 (05) :553-564
[44]   Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma [J].
Terpos, Evangelos ;
Ramasamy, Karthik ;
Maouche, Nadjoua ;
Minarik, Jiri ;
Ntanasis-Stathopoulos, Ioannis ;
Katodritou, Eirini ;
Jenner, Matthew W. ;
Plonkova, Hana ;
Gavriatopoulou, Maria ;
Vallance, Grant D. ;
Pika, Tomas ;
Kotsopoulou, Maria ;
Kothari, Jaimal ;
Jelinek, Tomas ;
Kastritis, Efstathios ;
Aitchison, Robin ;
Dimopoulos, Meletios A. ;
Zomas, Athanasios ;
Hajek, Roman .
ANNALS OF HEMATOLOGY, 2020, 99 (05) :1049-1061
[45]   Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States [J].
Richter, Joshua ;
Pan, Darren ;
Salinardi, Taylor ;
Rice, Megan S. .
EJHAEM, 2023, 4 (04) :984-994
[46]   Lebanese Real-World Experience in Treating Multiple Myeloma: A Multicenter Retrospective Study [J].
Nasr, Fadi ;
Al Ghoche, Ahmad ;
Diab, Saada ;
Nasr, Lewis ;
Ammanouil, Emmanuel ;
Riachy, Christelle ;
Hallit, Souheil ;
Chahine, Georges .
LEUKEMIA RESEARCH REPORTS, 2021, 15
[47]   Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma [J].
Huang, Shang-Yi ;
Chen, Tsai-Yun ;
Kuo, Ching-Yuan ;
Chen, Yeu-Chin ;
Lin, Sheng-Fung ;
Chang, Ming-Chih ;
Lv, Xinzhu ;
Yang, Betty ;
Chang, Cheng-Shyong .
ONCOLOGY REVIEWS, 2019, 13 (01) :15-22
[48]   Measurable residual disease in multiple myeloma: ready for clinical practice? [J].
Burgos, Leire ;
Puig, Noemi ;
Cedena, Maria-Teresa ;
Mateos, Maria-Victoria ;
Lahuerta, Juan Jose ;
Paiva, Bruno ;
San-Miguel, Jesus F. .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
[49]   Real-world outcomes and factors impacting treatment choice in relapsed and/or refractory multiple myeloma (RRMM): a comparison of VRd, KRd, and IRd [J].
Chari, Ajai ;
Richardson, Paul G. ;
Romanus, Dorothy ;
Dimopoulos, Meletios A. ;
Sonneveld, Pieter ;
Terpos, Evangelos ;
Hajek, Roman ;
Raju, Aditya ;
Palumbo, Antonio ;
Cain, Lauren E. ;
Blazer, Marlo ;
Huang, Hui ;
Farrelly, Eileen ;
Ailawadhi, Sikander .
EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (04) :421-433
[50]   Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients [J].
Lovas, Szilvia ;
Varga, Gergely ;
Farkas, Peter ;
Masszi, Tamas ;
Wohner, Nikolett ;
Bereczki, Agnes ;
Adamkovich, Nora ;
Borbenyi, Zita ;
Szomor, Arpad ;
Alizadeh, Hussain ;
Szaleczky, Erika ;
Wolf, Krisztina ;
Schneider, Tamas ;
Plander, Mark ;
Szendrei, Tamas ;
Csacsovszki, Otto ;
Csukly, Zoltan ;
Rajnics, Peter ;
Egyed, Miklos ;
Nagy, Zsolt ;
Rejto, Laszlo ;
Illes, Arpad ;
Mikala, Gabor ;
Varoczy, Laszlo .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 110 (05) :559-565